BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sudhoff H, Liebehenz Y, Aschenbrenner J, Jung J, Hildmann H, Dazert S. A murine model of cholesteatoma-induced bone resorption using autologous dermal implantation. Laryngoscope 2003;113:1022-6. [PMID: 12782815 DOI: 10.1097/00005537-200306000-00019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Lalam RK, Cassar-pullicino VN, Mangham C, Clewer G, Cool P. Progressive massive osteolysis secondary to benign squamous epithelial colonisation in chronic osteomyelitis. Skeletal Radiol 2006;35:876-81. [DOI: 10.1007/s00256-006-0091-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Jiang H, Si Y, Li Z, Huang X, Chen S, Zheng Y, Xu G, Chen X, Chen Y, Liu Y, Xiong H, Huang Q, Liang M, Zhang Z. TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation. Sci Rep 2016;6:38761. [PMID: 27934908 DOI: 10.1038/srep38761] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
3 Schürmann M, Greiner JFW, Volland-Thurn V, Oppel F, Kaltschmidt C, Sudhoff H, Kaltschmidt B. Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS. Cells 2020;9:E199. [PMID: 31947538 DOI: 10.3390/cells9010199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yamamoto-Fukuda T, Takahashi H, Koji T. Animal models of middle ear cholesteatoma. J Biomed Biotechnol. 2011;2011:394241. [PMID: 21541229 DOI: 10.1155/2011/394241] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xie S, Wang X, Ren J, Liu W. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma. Eur Arch Otorhinolaryngol 2017;274:2071-8. [DOI: 10.1007/s00405-016-4422-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
6 Ismi O, Karabulut YY, Bal KK, Vayisoglu Y, Unal M. Single dose intratympanic mesna application inhibits propylene glycol induced cholesteatoma formation. J Laryngol Otol 2017;131:215-20. [DOI: 10.1017/s002221511600983x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]